MediSpend's CEO & Co-Founder to Participate in Analytics Panel at GHC International Pharmaceutical and Medical Device Compliance Congress
PORTSMOUTH, New Hampshire, April 9, 2019 /PRNewswire/ -- MediSpend, a leader in cloud-based software for the global life sciences industry, will attend this year's 13th Annual GHC International Pharmaceutical and Medical Device Compliance Congress. Michaeline Daboul, MediSpend chief executive officer and co-founder, will participate in the "Analytics with Reference to Transparency and/or Monitoring" panel discussion on Tuesday, April 9, 2019 at 1:15 p.m. in Athens, Greece.
The session, "Analytics with Reference to Transparency and/or Monitoring," will explore how to leverage data to mitigate risk, enhance compliance monitoring, and improve business outcomes. As a panelist, Daboul will share insight on the role data analytics plays in compliance monitoring.
"Maintaining global consistency in policies and processes is one of the industry's toughest compliance challenges," said Daboul. "Moving compliance upstream to better collect data and monitor behavior assists in mitigating risk."
The 13th Annual GHC International Pharmaceutical and Medical Device Compliance Congress is meant to give the life sciences industry an opportunity to focus on pharmaceutical and medical device compliance code updates, issues related to transparency reporting, and related emerging trends. This conference brings together industry experts to discuss anti-corruption and anti-bribery policy, the EU's General Data Protection Regulation (GDPR), and updates on the new French Sapin II Law.
MediSpend is a global leader in cloud-based compliance software for the life sciences industry. MediSpend is the compliance system of record for some of the world's largest life sciences companies. We help pharmaceutical, medical device, dental, and emerging biotech companies comply with global healthcare laws while reducing risk and lowering costs. The MediSpend Compliance Cloud enables life sciences companies to manage and monitor physician engagement, aggregate and analyze enterprise data, and comply with global data privacy and transparency reporting regulations. Our employees are committed to customer success, innovation, and exceptional product development. Our customers are located in the United States, Europe, Asia, and Latin America. MediSpend is headquartered in Portsmouth, NH, with offices in Minnesota, New York, and Pennsylvania. Visit MediSpend online at www.medispend.com.